Issuu on Google+

Product Compendium (Ireland)

2012

AN IRISH OWNED COMPANY SUPPORTING LOCAL JOBS


Product Compendium (Ireland) Contents Foreward

3

Product Guide

4-11

Product Datasheets

12-119

Index of Products

120-121

Bimeda Sales Team

122

This compendium is up to date and accurate as of the date of issue (April 2012). To ensure accuracy of information subsequent to the issue date, please consult the SPC on www.imb.ie

2


Foreword Founded in Ireland in 1967, Bimeda速 has become one of the leading manufacturers and distributors of veterinary pharmaceuticals and animal health products in Ireland. We are the market originator and leader in teat seal products. Our original teat seal brand, Boviseal, is now widely used on Irish dairy farms. This technology has fundamentally changed mastitis control programs in the Irish dairy industry. The use of Boviseal will be critical for Irish dairy farmers to meet the Food Harvest 2020 target of a 50% increase in milk production by the end of the decade. It is a good example of how an Irish company can be at the forefront of innovation to drive our Agri-food sector to be best the best in the world. Headquartered in Dublin, our company employs over 130 people in Ireland and over 500 worldwide. We have seven manufacturing facilities in Ireland, USA, Canada, UK and Brazil. We also distribute

in Mexico and Kenya. We have a state of the art R & D/Regulatory Laboratory in Shijiazhuang, China. Our organisation develops and manufactures a wide range of veterinary products including; antibiotics, anti-inflammatories, intramammaries, scour treatments, ecto & endo parasiticides together with a comprehensive equine health portfolio. Our mission is to be recognized as a market leader in the commercial and companion animal health sectors across the globe, through our people, products, and customers. We are committed to improving health and wellness of pets and livestock around the world, by providing innovative, high quality products and solutions through excellence in research and development, manufacturing and above all customer service. Together with our customers, we aim to make the difference!

3


Code

1ABI001

1BIL001

Description ABINEX FORTE (Abamectin 10mg/ml)

BILOSIN 200 INJECTION (Tylosin 200mg/ml)

1BIM003

BIMADINE PDR (Sulfadimidine 25g)

1BIM018

1BIM027

BIMOTRIM CO. INJECTION (Sulphadoxine 200mg/ml/ Trimethoprim 40mg/ml)

BIMOXYL LA INJECTION (150mg/ml Amoxicillin)

1BIM052

1BIM068

1BIM098

1BIM123

1BIM156

1BIO001

1BOV024

1BOV010 4

BIMASTAT

Product Size 400ml, 1L, 2.5L

100ml

100 X 25g

100ml

100ml

(Sulphadiazine 150mg/ml, Neomycin 25mg/ml)

250ml, 1L

BIMECTIN INJECTION

50ml, 250ml, 500ml

(Ivermectin 10mg/ml)

BIMECTIN HORSE WORMER (Ivermectin 18.7 mg/g)

BIMECTIN POUR ON (Ivermectin 5mg/ml) Bimectin 0.5% Cattle Pour On Solution

BIMECTIN PLUS INJECTION (Ivermectin 10mg/ml, Clorsulon 100mg/ml)

BIOCOLOST B (Colostrum from selected and controlled herds)

BOVISAL PEARLS

6.42g Syringe

2.5L, 5L 50ml, 250ml, 500ml

100ml

(Calcium supplement for downer cows with added phosphorous and energy)

600g

BOVISEAL NA

120 syringes per container

(Bismuth Subnitrate 2.6g)

Species Cattle

Sheep

Equine


ctd. Pig

Dog

Cat

Poultry

Withdrawal Categ. Period Milk

Withdrawal Period Meat

Page

Do not use on non-lactating cows or within 60 days of calving.

35 days

12

POM

Nil

21 Days

14

POM

N/A

28 Days

16

POM

48 hours

5 Days

18

POM

72 hours

Cattle 18 days Sheep 21 days Pigs 11 days

20

POM

Nil

28 Days

22

LM

Do not use on lactating cows or within 60 days of calving.

Cattle 49 days Sheep 42 days Pigs 28 days

24

LM

N/A

34 days

26

LM

Not for use in animals producing milk for human consumption

28 Days IMB 31 days

28

LM

Not for use in lactating cows or in-calf dairy stock

66 Days

30

N/A

Nil

Nil

32

N/A

Nil

Nil

34

LM

Nil

Nil

36

LM

5


Code

1BOV011

Description BOVIMAST DC (Cloxacillin 500mg)

BOVIFERM PLUS

1BOV021 1BOV022

1EQU001

1CON007

1CRO003

1CYC002

1CYC001

1CYP003

1DIP010

CALCIUM BOVISAL (Minerals containing calcium, magnesium, phosphorous)

CONVITAL EQUILYTES (Contains potassium, magnesium and calcium ions concentrated in an amino acid chelate)

CONVITAL R

(Contains 7 essential vitamins and 11 vital minerals & trace elements in a balanced ratio)

CRONYXIN INJECTION (Flunixin 50mg/ml)

CYCLOSOL SPRAY (chlorotetracycline 200mg/ml)

CYCLOSOL LA INJECTION (Oxytetracycline 200mg/ml)

CYPERGUARD (Cypermethrin High Cis 10% w/w per ml)

DIPEN (Procaine Penicillin 200mg& Dihydrostreptomycin 200mg/ml) Procaine Penicillin 200mg & Dihydrostreptomycin 200mg/m

1ECT001

(Cypermethrin Technical 2.5% w/v)

8ECT008

120 syringes per container 24 x 115g Sachets

500ml

3 X 60g

4.5L

50ml, 100ml

211ml

100ml

1L, 2L

100ml

D-MITE

TBC

1ECT003

6

(Electrolytes, dextrose, Buffering agents, lactic acid bacteria, vegetable mucins and mineral bulking agents)

Product Size

ECTOSPEC

ECTOFLITS (Diazinon 60% w/w)

ECTOFLY (Cypermethrin)

2 x 5L

500ml, 2.5L

3L

5L

Species Cattle

Sheep

Equine


ctd. Pig

Dog

Cat

Poultry

Withdrawal Categ. Period Milk POM

Withdrawal Period Meat

Page

28 Days + 120 Hours

28 Days

38

N/A

Nil

Nil

40

N/A

Nil

Nil

42

LM

N/A

Nil

44

LM

N/A

Nil

46

POM

36 Hours

7 days. Not to be used in horses intended for human consumption.

48

POM

Nil

Nil

50

POM

12 days

Cattle 30 days Pigs 30 days

52

N/A

14 days

54

POM

Nil 72hrs

Pigs and Cattle 21 days

56

TBC

TBC

TBC

58

LM

Nil

10 days

60

LM

N/A

35 days

62

LM

64 7


Code 1EFI001

1EMB001

1END009

1END002

1END023

1EQU005

1FLE003

1HEL002

1HYS002

Description EFICUR (Ceftiofur 50mg/ml)

EMBOTAPE HORSE WORMER (Pyrantel embonate 400mg/g)

ENDOSPEC 2.5% SC (Albendazole 25 mg, Selenium 0.27mg, Cobalt 0.24mg/ml)

ENDOSPEC 10% SC (Albendazole 100 mg/ml)

ENDOFLUKE 10 (Triclabendazole 100mg/ml)

EQUIBACTIN (Trimethoprim 66.7mg, Sulfadiazine 333.3mg/g)

FLEE (Flee Household Flea Spray)

HELODIP (Ammonium Lauryl Sulphate 3.1 % w/v)

HYSPAN 400 MG ORAL POWDER (Neomycin Sulphate 4mg/g)

KEFAMAST DRY COW

1KEF002

(Anhydrous Cefalexin 500 mg Dihydrostreptomycin 500mg/syringe)

1KEF010

(Cephalexin 500mg Dihydrostreptomycin 500mg/10ml)

KEFAMAST LACTATING COW

MULTIMAST DRY COW 1MUL004

8

(Neomycin Sulphate 100mg Penethamate Hydriodide 100mg Procaine Benzylpenecillin 400mg/4.5g syringe)

TBC

NEFOTEK (Nefotek 100 mg/ml solution for injection)

1OSM004

(Contains 1.99% w/w of available Iodine)

OSMODEX

Product Size 100ml

28.5g

2.5L, 5L

1L, 2.5L, 5L

1L, 2.5L

45g Syringe

400ml

5L, 20L

100g Sachets

120 syringes per container 24 syringes per container 120 syringes per container

100ml, 250ml

5L, 25L

Species Cattle

Sheep

Equine


ctd. Pig

Dog

Cat

Poultry

Withdrawal Categ. Period Milk

Withdrawal Period Meat

Page

POM

Nil

Pigs and Cattle 2 days 8 days

66

LM

N/A

7 Days

68

LM

60 Hours

Sheep 4 Days Cattle 14 days

70

LM

60 hours

Cattle: 14 days Sheep: 4 days

72

LM

Not permitted for use in lactating cows.

56 days

74

POM

N/A

14 Days

76

POM

N/A

N/A

78

LM

Nil

Nil

80

POM

N/A

28 Days

82

POM

40 Days + 60 hours

28 days

84

POM

96 hours

7 days

86

POM

50 days + 96 hours

28 days

88

N/A

N/A

90

LM

92 9


Code

Description

1OXY003

(Oxytetracycline hydrochloride equivalent to Oxytetracycline 10mg. Flunixin Meglumine equivelant to Flunixin 20mg/ml)

1OXY037

1RAP001

OXYCOMPLEX NS INJECTION

OXYTOCIN INJECTION (synthetic) 10 I.U. per ml

RAPIDEXON 2MG INJECTION (Dexamethasone 2mg/ml)

SEDAXYLAN INJECTION

1SED001

(Xylazine 20mg Equivelant to 23.32mg xylazine hydrochloride/ml)

1SEL001

(Florfenicol 300mg/ml)

1SUL003

1TET015

SELECTAN INJECTION

SULPHADIMIDINE PDR (Sulfadimidine Sodium 1000mg/g)

TETROXY LA INJECTION (Oxytetracycline Ph. Eur. 200 mg/ml)

1TON002

TONAVET (Multivitamin tracel element tonic for animals)

1TYL009

TYLOVET 20% INJECTION (Tylosin 200mg/ml)

1UNI001

UNISOL (Enrofloxacin 100mg/ml)

1VET005

VETRISUL (Trimethoprim 40g, Sulphamethoxazole 200mg/ml)

VITAMIN B1 INJECTION

1VIT001

(Thiamine Hydrochloride Ph. Eur. 100 mg/ml)

1VIT014

(Phytomenadione 10mg/ml)

10

Product Size

VITAMIN K1 INJECTION

100ml

50ml

100ml

25ml

100ml

25g Sachets

100ml

500ml, 2.5L

100ml

100ml

100ml

50ml

50ml

Species Cattle

Sheep

Equine


ctd. Pig

Dog

Cat

Poultry

Withdrawal Categ. Period Milk

Withdrawal Period Meat

Page

POM

5 Days

28 days

94

POM

Nil

Nil

96

POM

72 hours

Cattle 7 days Pig 2 days Horse 11 days

98

POM

Nil

1 day

100

POM

Not permitted for use in lactating animals producing milk for human consumption

Cattle 30 days Pigs 18 days

102

POM

5 Days

Cattle 21 days Poultry 14 days

104

POM

7 days

Cattle & Sheep 28 Days Pigs 21 days

106

Nil

Nil

108

POM

4 days

21 days

110

POM

Cattle Subcut. 84 hrs, Intraven. 72 hrs

Cattle Subcut. 13 days, Intraven. 4 days Pigs intramus. 10 days

112

POM

Cattle 5 days

Cattle 35 days

114

POM

Nil

Nil

116

POM

7 days

28 days

118

N/A

11


12


13


14


15


16


17


18


19


20


21


22


23


24


25


26


PRESENTATION A yellow gel-like, apple flavoured, paste of uniform consistency, containing 1.87% w/w Ivermectin. USES Bimectin Horse Paste is indicated for the treatment nematode or arthropod infestations in horses due to: Large strongyles: Strongylus vulgaris (adults and 4th larval [arterial] stages), S. edentatus (adults & 4th larval [tissue] stages), S. equinus (adults), Triodontophorus spp. (adults), Triodontophorus brevicauda, Triodontophorus serratus. Small Strongyles: Adult and immatures (fourth stage larvae) small strongyles or cyathostomes unless otherwise stated. Ivermectin is not effective against the encysted larval stages of the small strongyles.: Coronocyclus spp., Cyathostomum spp., Cylicocyclus spp., Cylicostephanus spp., Cylicodontophorus spp., , Parapoteriostomum spp., Petrovinema spp., Poteriostomum spp. Lungworms (adult andinhibited fourth stage larvae): Dictyocaulus arnfieldi Pinworms (adult and inhibited fourth stage larvae): Oxyuris equi Ascarids (adults and third & fourth stage larvae): Parascaris equorum Hairworms (adults): Trichostrongylus axei Large-mouth stomach worms (adults): Habronema muscae Neck threadworms (microfilariae): Onchocerca spp. Intestinal threadworms (adults): Strongyloides westeri Stomach bots: Oral and gastric stages of Gasterophilus spp. DOSAGE AND ADMINISTRATION Administer orally as a single dose rate to horses at the recommended dose level of 0.2mg ivermectin per kilogram of bodyweight. Each syringe delivers 120mg ivermectin, sufficient to treat 600kg of bodyweight. Single administration. Bodyweight and dosage should be accurately determined prior to treatment. DOSING INSTRUCTIONS Each weight marking on the syringe plunger will deliver sufficient paste to treat 100kg bodyweight. Unlock the knurled ring by making ¼ turn and slide the knurled ring up the plunger shaft so that the side nearest the barrel is at the prescribed weight

marking. Turn the knurled ring ¼ turn to lock in place. Make sure the horse’s mouth contains no feed. Remove the plastic cap from the tip of the nozzle. Insert the syringe into the horse’s mouth at the inter-dental space. Advance the plunger as far as it will go, depositing the medication on the base of the tongue. Immediately raise the horse’s head for a few seconds after dosing. The treatment schedule should be based on the local epidemiological situation. CONTRA-INDICATIONS, WARNINGS, ETC Special warning for non-target species: The product has been formulated for use in horses only. Cats, Dogs, especially Collies, Old English Sheepdogs and related breeds or crosses, and also turtles and tortoises may be adversely affected by the concentration of ivermectin in this product if they are allowed to ingest spilled paste or have access to used syringes. Do not use in mares producing milk for human consumption.Studies performed in laboratory animals showed no teratogenic or embryotoxic affect of ivermectin at the recommended doses during therapy. The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Use only according to risk/benefit analysis by the responsible veterinary surgeon. Some horses carrying heavy infection of Onchocerca microfilariae have experienced oedema and pruritus following dosing, assumed to be the result of death of large numbers of microfilariae. These signs resolve within a few days but symptomatic treatment may be advisable. Ivermectin is extremely dangerous to fish and aquatic life. Treated animals should not have direct access to surface waters and ditches during treatment. Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class.

includes mydriasis, ataxia, tremors, stupor, coma and death. The less severe signs have been transitory. No antidote has been identified; however, symptomatic therapy may be beneficial. WITHDRAWAL PERIODS Meat and offal 34 days. Not permitted for use in mares producing milk for human consumption. OPERATOR WARNINGS Do not eat, drink or smoke while handling the product. Avoid contact with skin and eyes. If accidental skin contact occurs, wash the affected area immediately with soap and water. If accidental eye exposure occurs, flush the eyes immediately with water and, if necessary, get medical attention. Wash hands after use. Extremely dangerous to fish and aquatic life. Do not contaminate surface waters or ditches with product or used containers. Any unused product or waste material should be disposed of in accordance with national requirements. PHARMACEUTICAL PRECAUTIONS Following intensive exposure to sunlight photolytic degradation of ivermectin may occur. This is a single dose product. Discard after use. Keep out of reach and sight of children. LEGAL CATEGORY

LM

PACKAGE QUANTITIES High density polyethylene pre-filled dose-graduated disposable syringe containing 6.42 g of product. VPA 10960/48/1

OVERDOSE Mild transitory signs (slowed pupillary light response and depression) have been seen at a dose of 1.8mg/kg (9 times the recommended dose level). Other signs seen at higher doses

27


28


29


30


31


32


BIOCOLOST B

PURPOSE

FEEDING INSTRUCTIONS

COMPOSITION

CONTENTS SHELF LIFE AND STORAGE INSTRUCTIONS

PACK SIZE

33


34


35


36


37


38


39


40


41


42


43


44


45


46


47


48


PRESENTATION Cronyxin Injection is a clear, sterile, aqueous solution for injection. Each ml contains Flunixin 50mg (as Flunixin Meglumine), Phenol 5mg (preservative), Sodium Formaldehyde Sulfoxylate (antioxidant) and Propylene Glycol (co-solvent). USES Cattle For the control of acute inflammation associated with respiratory disease. For use as adjunctive therapy in the treatment of acute mastitis. Horses For the alleviation of inflammation and pain associated with musculoskeletal disorders. For the alleviation of visceral pain associated with colic. DOSAGE AND ADMINISTRATION Cattle The recommended dose is 2ml Cronyxin injection per 45kg bodyweight (equivalent to 2.2mg flunixin per kg) injected intravenously and repeated as necessary at 24 hour intervals for up to 5 consecutive days. The cause of the acute inflammatory condition should be determined and treated with concomitant therapy. Horses For use in equine musculoskeletal disorders, the recommended dose is 1ml Cronyxin Injection per 45kg bodyweight (equivalent to 1.1mg flunixin per kg) injected intravenously and repeated as necessary at 24 hour intervals for up to 5 consecutive days according to response. For use in equine colic, the recommended dose is 1ml Cronyxin Injection per 45kg bodyweight (equivalent to 1.1mg flunixin per kg) injected intravenously and repeated once or twice if signs of colic recur. The cause of colic should be determined and treated with concomitant therapy. CONTRAINDICATIONS, WARNINGS ETC. Do not exceed the recommended dose or treat animals for more than 5 consecutive days. Use is contra-indicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastrointestinal ulceration or bleeding, where there is evidence of a blood dyscrasia or hypersensitivity to the product. Avoid intra-arterial injection. Avoid use in dehydrated, hypovolemic or hypotensive animals as there is a potential risk of increased renal toxicity. Not to be used in animals with known hypersensitivity to the active ingredient. For animal treatment only. UNDESIRABLE EFFECTS (GENERAL) Prolonged use of NSAIDs, including flunixin, may predispose or lead to gastro-intestinal irritation, and in severe cases, ulceration. SPECIAL PRECAUTIONS FOR USE NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infections appropriate concurrent antimicrobial therapy should be instigated. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs to produce an increase in non-bound pharmacologically active concentrations, which can lead to toxic effects. Use in any animal less than 6 weeks of age or

in aged animals may involve additional risk. If such use cannot be avoided animals may require a reduced dosage and careful clinical management. It is preferable that flunixin is not administered to animals undergoing general anaesthesia until fully recovered. Concurrent administration of potentially nephrotoxic drugs should be avoided.. USE DURING PREGNANCY AND LACTATION Do not administer to pregnant mares. Studies to demonstrate safety in pregnant mares have not been conducted. DRUG INTERACTIONS Do not mix Cronyxin with other medicaments prior to administration. Monitor drug compatibility closely where adjunctive therapy is required. Cronyxin may potentiate the effects of warfarin and other such drugs. Do not administer other NSAIDs concurrently or within 24 hours of each other. Due to their common mode of action, flunixin may potentiate and be potentiated by other NSAIDs which act by interfering with prostaglandin synthesis. WITHDRAWAL PERIOD(S) Milk from lactating cows should be discarded during treatment and may only be taken for human consumption after 36 hours following treatment. Animals may not be slaughtered for human consumption during treatment. Animals may be slaughtered for human consumption only after 7 days from the last treatment. Not for horses intended for human consumption. PHARMACEUTICAL PRECAUTIONS Keep out of reach and sight of children. Do not store above 25°C. Following withdrawal of the first dose, use the product within 28 days. Avoid the introduction of contamination during use. Should any apparent growth or discolouration occur, the product should be discarded. LEGAL CATEGORY PACKAGE QUANTITIES 250ml and 1 litre FUTHER INFORMATION Non-steroidal anti-inflammatory drugs are not permitted substances under the Rules of Racing and under rules covering other competitive events. Veterinary surgeons administering NSAIDs to racehorses should refer to Section 4.4 of the RCVS Guide to Professional Conduct. Section 4.4.7 states ‘If a veterinarian recommends the discontinuance of any substance…….. not less than eight days before racing (even though such period may be longer than is necessary in many instances) he should be able to feel that he has catered for all but the most exceptional cases’. VPA 10126/064/001

49


50


PRESENTATION

TARGET SPECIES

USES WITHDRAWAL PERIOD(S)

SHELF-LIFE

STORAGE

CONTRAINDICATIONS, WARNINGS ETC

DISPOSAL

OPERATOR WARNINGS

PACKAGE QUANTITIES

LEGAL CATEGORY DOSAGE AND ADMINISTRATION

VPA

51


52


LEGAL CATEGORY

53


54


55


56


PRESENTATION The product is a white to off-white sterile aqueous suspension for injection. Each ml contains: Procaine Penicillin 200 mg (equivalent of 200,000 IU) Dihydrostreptomycin sulphate 200 mg Methylhydroxybenzoate 1.0 mg USES For the treatment of infections caused by bacteria sensitive to penicillin and dihydrostreptomycin in cattle, sheep and pigs. DOSAGE AND ADMINISTRATION The recommended dose is 4 ml per 100 kg bodyweight i.e. 8,000 IU procaine penicillin and 10 mg dihydrostreptomycin sulphate per kg. Dipen is to be administered by sterile intramuscular administration only. Clean the area of injection and swab with spirit. Dose Rate per Species (ml) kg Bodyweight Cattle 4.0 100 Sheep 1.0 25 Sow 3.0 75 Piglet 0.2 5 Do not exceed the stated dose CONTRAINDICATIONS AND WARNINGS Do not administer to animals known to be sensitive to penicillin. Do not use when it is known that penicillinase-producing staphylococcus organisms are present. Occasionally in sucking and fattening pigs, administration of products containing procaine penicillin may cause a transient pyrexia, vomiting, shivering, listlessness and incoordination. In pregnant sows and gilts a vulval discharge which could be associated with abortion has been reported. The maximum dose volume recommended at any one site for cattle is 20 ml. WITHDRAWAL PERIODS Withdrawal Period(s): Cattle: Meat : 21 days. Milk: 72 hours. Sheep: Meat: 21 days Milk: Not to be used in lactating ewes producing milk for human consumption. Pigs: Meat: 21 days. Animals are not to be slaughtered to produce meat for human consumption during treatment. Milk for human consumption is not to be taken from cows during treatment. PHARMACEUTICAL INFORMATION AND PRECAUTIONS Contraindications: Do not administer to animals known to be sensitive to penicillin. Do not use when it is known that penicillinaseproducing staphylococcus organisms are

present. Special warnings: Occasionally in sucking and fattening pigs, administration of products containing procaine penicillin may cause a transient pyrexia, vomiting, shivering, listlessness and incoordination. In pregnant sows and gilts a vulval discharge which could be associated with abortion has been reported. The maximum dose volume recommended at any one site for cattle is 20ml. SPECIAL PRECAUTIONS FOR USE IN ANIMALS: Not for use in lactating ewes producing milk for human consumption. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Penicillin and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillin may lead to cross sensitivity to cephalosporins and vice versa. Allergic reaction to those substances can occasionally be serious. Do not handle this product if you know you are sensitised or if you have been advised not to work with such preparations. Handle this product with great care to avoid exposure, taking all recommended precautions. If you develop symptoms following exposure, such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips and eyes or difficulty with breathing are more serious symptoms and require urgent medical attention. Adverse reactions: Occasional allergies to penicillins have been observed but these are very rare. Hypersensitivity (allergic) reactions to penicillins can vary from localised swelling to anaphylaxis and death. Occasionally in sucking and fattening pigs administration of products containing procaine penicillin may cause transient pyrexia, vomiting, shivering, listlessness and incoordination. In pregnant sows and gilts a vulval discharge which could be associated with abortion has been reported. Procaine penicillin G can, under certain circumstances, be toxic and even lethal to pigs and this is thought to be due to a sudden release of toxic amounts of free procaine. The symptoms include shivering, lassitude, inappetence, vomiting, cyanosis of the extremities and pronounced pyrexia (40째C and over). A vulval discharge may appear and some animals may abort. Alarming sideeffects are most likely to occur when pigs with erysipelas are injected with an older and, or,

heataffected procaine penicillin formulation. Treatment with 5 mg dexamethasone will result in rapid recovery. USE DURING PREGNANCY, LACTATION OR LAY: Procaine penicillin and dihydrostreptomycin are safe for use in pregnant animals. Not for use in lactating ewes producing milk for human consumption. Interaction with other medicinal products and other forms of interaction: Tetracyclines are bacteriostatic antibiotics that presumably may interfere with a bactericidal agent such as penicillin. Since penicillin acts by inhibiting cell wall synthesis, agents such as tetracyclines, which inhibit protein synthesis, could mask the bactericidal effect of penicillin. If penicillin is used with a tetracycline, it would be prudent to observe the following points when possible: Be sure that adequate amounts of each agent are given; antagonism is most likely to occur when barely sufficient amounts of each agent are given. Begin administration of the penicillin at least a few hours before the administration of tetracycline. SHELF-LIFE The shelf life is two years from the date of manufacture. Once a vial is broached, use the contents within four weeks. SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25째C. Do not freeze. NATURE AND COMPOSITION OF IMMEDIATE PACKAGING: Type II, Siliconised clear glass, 100 ml vials containing closed with rubber stoppers and sealed with aluminium seals. Special precautions for the disposal of unused veterinary medicinal products or waste materials: Unused product or waste material should be disposed of in accordance with current practice for pharmaceutical waste under national disposal regulations. LEGAL CATEGORY POM MARKETING AUTHORISATION HOLDER CrossVetpharm Ltd (trading as Bimeda), Broomhill Road, Tallaght, Dublin 24. MARKETING AUTHORISATION NUMBER VPA: 10960/062/001

57


58


59


60


61


62


63


ECTOFLY 1.25% w/v Pour-On Solution Cypermethrin

64


65


66


67


68


69


70


71


72


73


74


75


76


77


78


FLEE When this is sprayed on a flea, it evaporates off after 20 minutes, leaving a gum/glue on the outer skin of the parasite. Staining on household surfaces is minimal and the ‘wet look’ usually fades once dry. FLEE does not feel sticky to touch. It is non-insecticidal and non-pesticidal. It is effective against adults, larvae, eggs and pupae. As a result, adults and mobile larvae are ‘glued up’ (adults within 1 min, larvae in 10mins) and eventually die of starvation. Eggs and Pupae are coated in sticky layer and continue to physically develop but cannot emerge from their chitin sac. FLEE also ‘Glues’ adult dust mites and their integumentary material (debris and faeces). Due to its non-insecticidal mode of action, resistance is not an issue. The adhesive effects of FLEE persist for 6 days in deep carpet, immobilising all adults and larvae for 6 days after application. It is not orally toxic to pets. FLEE has very low toxic levels in general. It is not absorbed following oral/ dermal exposure. FLEE reduces dust mite allergens (Thornton & Ross). This product is effective for at least 6 weeks (reapply every 6 weeks at the most). Vacuuming is NOT required after application. You do not need to treat the whole house, merely the areas in contact with your Pet. DIRECTIONS FOR USE: Shake can well before use. Direct nozzle approximately 40 cm from the surface you want to treat and away from your body. Using a sweeping motion to ensure uniform delivery, apply a 14 second spray per square metreon carpets, upholstered furniture and pet bedding. If spraying large areas shake can occasionally to maintain an even distribution of product. Wash your hands after use.

YOU DO NOT need to ventilate the room after application. Not orally toxic to pets. Very low toxic levels in general. Not absorbed following oral/dermal exposure. FLEE reduces dust mite allergens (Thornton & Ross). FLEE is effective for at least 6 weeks (re-apply every 6 weeks at the most). Vacuuming is NOT required after application. Does not need to treat whole house, merely areas in contact with Pet. DO NOT need to ventilate the room after application PRECAUTIONS: Keep away from food and drinks. Avoid eye contact. If your eyes are accidentally affected, flush with plenty of clean water. Seek medical advice if irritation persists. Due to the oily nature of the ingredients, some surfaces could be slightly slippery before they dry. Take necessary precautions if this is the case. FLEE can be used on most surfaces.However, before use on large surfaces or potentially delicate fabrics such as leather, we recommend that you test a small, out-of-sight area to check the suitability of the product with the material.

Special precautions for the disposal of unused veterinary medicinal product or waste material derived from the use of such products: Any unused veterinary medicinal product or waste material derived from such veterinary medicinal products should be disposed of in accordance with local requirements. Distributed in Ireland by Bimeda in partnership with Excella-tec, a division of Cross Vetpharm Group Ltd., Broomhill Road, Tallaght, Dublin 24, Ireland Distributed in UK by Bimeda in partnership with Excella-tec, Bryn Cefni Industrial Park, Llangefni, Anglesey, LL77 7XA, Wales

WARNINGS: Pressurised container: protect from sunlight and do not expose to temperatures exceeding 50°C. Do not pierce or burn even after use. Do not spray on or near a naked flame, electrical equipment or any incandescent material. Keep away from sources of ignition – No smoking. Keep can out of the reach and sight of children. Use only as directed. Please recycle when empty. FLEE contains a patented combination of silicones. Due to their mechanical mode of action, these active ingredients are considered exempt under the Biocides Directive.

You may notice slightly darker shading on sprayed surfaces. This is normal and will disappear as the product dries off completely. Hard non-porous surfaces should not normally require application. If sprayed such surfaces will appear wet for approximately 30 minutes after treatment and may present a slip hazard until dry.

79


80


81


82


83


84


85


86


87


88


89


90


TARGET SPECIES Cattle, pigs and horses INDICATIONS Cattle: Anti-inflammatory and analgesic treatment of diseases in the musculoskeletal system and the udder. Pigs: Anti-inflammatory and antipyretic treatment of Mastitis Metritis Agalactia Syndrome and respiratory diseases. Horses: Anti-inflammatory and analgesic treatment of diseases in the musculature, joints and the skeleton. Symptomatic analgesic treatment for colic. Postoperative pain and swelling. BENEFITS Suitable for pigs, cattle and horses. Wide range of indications. Excellent analgesic, anti-inflammatory and antipyretic properties Short meat and no milk withdrawal periods. Suitable for symptomatic colic treatment in horses. Suitable for treatment of postoperative pain and swelling. PRESENTATION Clear solution for injection One ml contains: Active substance Ketoprofen 100 mg EXCIPIENTS Benzyl alcohol USES Cattle: Anti-inflammatory and analgesic treatment of diseases in the musculoskeletal system and the udder. This can include - the supportive treatment of parturient paresis associated with calving; - reducing the pyrexia and distress associated with bacterial respiratory disease when used in conjunction with antimicrobial therapy as appropriate; - improving the recovery rate in acute clinical mastitis, including acute endotoxin mastitis, caused by gram negative micro-organisms, in conjunction with antimicrobial therapy. - reducing oedema of the udder associated with calving. Pigs: Anti-inflammatory and antipyretic treatment of Mastitis Metritis Agalactia Syndrome and respiratory diseases. This can include; reducing the pyrexia and respiratory rate associated with bacterial or viral respiratory disease when used in conjunction with antimicrobial therapy as appropriate. The supportive treatment of Mastitis Metritis Agalactia Syndrome in sows, in conjunction with antimicrobial therapy as appropriate Horses: Anti-inflammatory and analgesic treatment of diseases in the musculature, joints and

the skeleton This can include - Diseases affecting the osteoarticular and muscular-skeletal system associated with acute pain and inflammation: - Lameness of traumatic origin - Arthritis - Osteitis, spavin - Tendinitis, bursitis - Naviculitis - Laminitis - Myositis Symptomatic analgesic treatment for colic. Postoperative pain and swelling. DOSAGE AND ADMINISTRATION Cattle: 3 mg ketoprofen/kg b.w., equivalent to 3 ml of NEFOTEK /100 kg b.w. intravenously or intramuscularly once a day for 3 to 5 days. Pigs: 3 mg ketoprofen/kg b.w., equivalent to 3 ml of NEFOTEK /100 kg b.w. intramuscularly once a day for 3 to 5 days. Horses: 2.2 mg ketoprofen/kg b.w, equivalent to 1 ml of NEFOTEK /45 kg b.w. Intravenously once per day for 3 to 5 days. In the case of colic, treatment should not be repeated until a clinical re-examination has been carried out. CONTRAINDICATIONS AND WARNINGS Do not use in severe renal failure. Do not use in conditions with a tendency to increased bleeding. Do not use in case of known hypersensitivity to ketoprofen. In the absence of specific tolerance data for very young foals, foals less than 15 days old should not be treated. Avoid intra-arterial injection. Do not exceed the stated dose or duration of treatment. Use with caution in dehydrated animals and animals with low blood pressure. In the case of colic a supplementary dose may only be given after a thorough clinical examination. Special precautions to be taken by the person administering the veterinary medicinal product to animals. Avoid splashes on the skin and eyes. Irrigate thoroughly with water should this occur. ADVERSE REACTIONS (frequency and seriousness) Repeated intramuscular injections can cause temporary irritation. Due to its mechanism of action including inhibition of prostaglandin synthesis, ketoprofen can cause gastric and intestinal irritation or ulceration. Use during pregnancy, lactation or lay. Studies of the effect of ketoprofen in pregnant laboratory animals and cattle have not produced any evidence of adverse effects. The effect on pregnant mares or sows has not been established. Concurrent administration with other non-steroidal antiinflammatory drugs and steroids is to be avoided. Ketoprofen can counteract the diuretic effect of

loop diuretics. Concurrent treatment with anticoagulants should be avoided because of the increased risk of haemorrhage. WITHDRAWAL PERIODS Meat and offal: Cattle 4 days, pigs 4 days, horses 4 days, Milk: Zero days. NOTE Ketoprofen, in common with other nonsteroidal anti-inflammatorys is not permitted by Racing Authorities of Great Britain and Ireland to be used at the time of racing. Ketoprofen or its conjugates can be detected in urine for up to 10 days after treatment (analytical sensitivity of 50ng/ml). An interval of 15 days from cessation of treatment should ensure that the drug is undetectable in most horses. PHARMACEUTICAL INFORMATION AND PRECAUTIONS: Non-steroidal anti-inflammatory/antirheumatic agent (NSAID). The active component of NEFOTEK is ketoprofen, a substance belonging to the group non-steroidal anti-inflammatory drugs (NSAIDs). Ketoprofen has anti-inflammatory, analgesic and antipyretic properties. Not all aspects of its mechanism of action are known. Effects are obtained partially by the inhibition of prostaglandin and leukotriene synthesis by ketoprofen, acting on cyclooxygenase and lipoxygenase respectively. The formation of bradykinin is also inhibited. Ketoprofen inhibits thrombocyte aggregation. List of excipients L Arginine, Benzyl alcohol, Citric acid monohydrate, Water for injections In the absence of compatibility studies, NEFOTEK must not be mixed with other medicinal products. Shelf life of the veterinary medicinal product as packaged for sale: 1 year. Shelf life after first opening the immediate packaging: 28 days. Special precautions for storage. Store below 25 C. Store in the original package. Protect from light. 6.5 Nature and composition of immediate packaging NEFOTEK is packaged in amber type II glass vials of 100 ml and 250 ml. Any unused veterinary medicinal product or waste materials derived from such Veterinary Medicinal product should be disposed of in accordance with local requirements LEGAL CATEGORY:

POM

MARKETING AUTHORISATION HOLDER: Bimeda Chemicals Ltd., Broomhill Road, Tallaght, Dublin 24, Ireland. MARKETING AUTHORISATION NUMBER: Vm:

91


92


93


94


OXYCOMPLEX NS Oxytetracycline hydrochloride Flunixin Meglumine PRESENTATION A clear yellow to amber aqueous solution for injection. Each ml contains 100mg Oxyteracycline (as oxytetracycline hydrochloride) and 20mg Flunixin ( as flunixin meglumine) TARGET SPECIES Cattle. INDICATIONS FOR USE For the control and treatment of infectious diseases of cattle caused by or associated with organisms sensitive to oxytetracycline, where concurrent analgesic, anti-inflammatory, antiendotoxic or antipyretic therapy is desired. The product is especially indicated for the treatment of respiratory disease (particularly that associated with Mannheimia and Pasteurella infection) and acute mastitis (in conjunction with appropriate intramammary therapy) CONTRAINDICATIONS Do not administer other NSAIDs concurrently or within 24 hours of each other. Use is contra-indicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastro-intestinal ulceration or bleeding, where there is evidence of a blood dyscrasia or hypersensitivity to the product. SPECIAL WARNINGS FOR EACH TARGET SPECIES Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs to produce an increase in non-bound pharmacologically active concentrations, which can lead to toxic effects. Rapid intraveneous injection in cattle may occasionally cause cardiovascular collapse. Use in any animal less than 6 weeks of age or in aged animals may involve additional risk. If such use cannot be avoided animals may require a reduced dosage and careful clinical management. Avoid use in any dehydrated, hypovolaemic or hypotensive animal as there is a potential risk of renal toxicity. It is preferable that flunixin is not administered to animals undergoing general anaesthesia until fully recovered. Concurrent administration of methoxyflurane anaesthesia or other potentially nephrotoxic drugs should be avoided.

SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals Do not exceed the stated dose or duration of treatment. ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals Avoid eye contact and direct contact with skin. To avoid possible sensitisation reactions, avoid contact with skin. Gloves should be worn during application. Wash hands after use. In case of accidental contact with eyes, rinse immediately with plenty of water and seek medical advice. The product may cause reactions in sensitive individuals. If you have known hypersensitivity for non-steroidal anti-inflammatory products, do not handle the product. Reactions may be serious. Avoid accidental self-injection. ADVERSE REACTIONS Prolonged use of NSAIDs, including flunixin, may predispose or lead to gastrointestinal ulceration. USE DURING PREGNANCY, LACTATION OR LAY Reports of teratogenicity, effects on breeding performance, or gestation lengths have not been noted following use of flunixin. Use with care in pregnant animals. The use of tetracyclines during the period of tooth development, including late pregnancy, may lead to tooth discolouration. INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTIONS The product may potentiate the effects of Warfarin and related drugs. Because of their common mode of action, flunixin may potentiate and be potentiated by other NSAIDs which act by interfering with prostaglandin synthesis. AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE 1 ml per 10 kg bodyweight (equivalent to 10 mg oxytetracycline and 2 mg flunixin per kg bodyweight) daily for up to 5 days. The first injection should be administered intravenously, slowly, with subsequent injections given intramuscularly. Do not inject more than 20 ml intramuscularly at a single site. Where the dose exceeds 20 ml it should be divided between two or more sites, as appropriate. OVERDOSE

Overdosing by intramuscular injection may give rise to swellings at the site of injection. Treatment should be symptomatic. WITHDRAWAL PERIODS Meat: Animals must not be slaughtered for human consumption during treatment. Cattle may be slaughtered for human consumption only after 28 days following the last treatment. Milk: Do not use in cattle producing milk for human consumption. INCOMPATIBILITIES None. SHELF LIFE (a) Shelf-Life – of the veterinary medicinal product as packaged for sale: 2 years (b) Shelf-Life - after first opening the immediate packaging: 28 days SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25°C. Protect from light. Following withdrawal of the first dose, use the product within 28 days. Discard unused material. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED MEDICINAL PRODUCT OR WASTE MATERIALS, IF ANY Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. MARKETING AUTHORISATION HOLDER Cross Vetpharm Group Limited, Broomhill Road, Tallaght, Dublin 24, Ireland MARKETING AUTHORISATION NUMBER VPA 10126/063/001 LEGAL CATEGORY POM PACKAGE QUANTITIES 100ML MULTIDOSE VIALS A full product SPC is available on request from Bimeda or alternatively can be found on the IMB website

95


96


97


98


99


100


101


102


103


104


PRESENTATION A white or creamy white odourless powder. Sulphadimidine Sodium 1000 mg. TARGET SPECIES Cattle and poultry. USES For the treatment of infections caused by micro-organisms (both bacteria and Coccidia) susceptible to Sulphadimidine. CONTRAINDICATIONS, WARNINGS ETC. Do not use in animals with serious liver and renal disturbances or in animals with diseases accompanied with a decreased intake of fluids or a decreased urine production or in cases of aciduria. Do not use in animals with damage to the haematopoietic system. Do not administer to laying hens. Do not use in case of hypersensitivity to the active ingredient. After administration of this product to ruminants, sometimes a temporary interference with ruminal function and microfloral activity may occur. However, spontaneous recovery is likely. Monitor water intake in poultry and calves during treatment. OPERATOR WARNINGS Avoid skin contact with the powder and avoid inhalation of the dust. pronounced in cases of decreased diuresis). USE DURING PREGNANCY, LACTATION OR LAY The safety of the veterinary medicinal product has not been established during pregnancy, lactation or lay. Use only accordingly to the benefit/ risk assessment by the responsible veterinarian.

Interaction with other medicinal products Simultaneous administration with para-aminobenzoic acid, its esters (e.g. procaine, tetracaine) and methenamine must be avoided. DOSES AND ADMINISTRATION For oral administration via the drinking water. Calves: 100 mg per kg bodyweight. Dosage interval: 12-24 hours. Duration: 3-5 days. Poultry (non laying hens and broilers): 100 mg per kg bodyweight (1 g powder per 1 – 2 litres drinking water, depending on actual water intake) Acute Coccidiosis: Administration during 3 consecutive days; after 2 days of no treatment, another 3 day treatment. Subclinical Coccidiosis: Administration for 3 consecutive days. OVERDOSE Acute overdose: Following an overdose a clear drop in water intake will occur in poultry. Administration to calves via the artificialmilk may lead to a retarded uptake of water and to diarrhoea. Chronic overdose: Haemorrhagic symptoms have been reported after long term administration of sulphonamides. A certain degree of immunosupression may occur making the animals more susceptible to secondary bacterial infections (especially gangrenous dermatitis in poultry). All undesirable effects documented under 4.6 may also occur following chronic overdosing.

WITHDRAWAL PERIOD(S) Poultry: Meat & offal: 14 days. Do not administer to laying hens. Cattle: Meat & offal: 21 days Milk: 5 days (i.e. 11th milking) SHELF-LIFE Shelf-life of the veterinary medicinal product as packaged for sale: 2 years Shelf-life after dilution or reconstitution according to directions: 24 hours STORAGE Do not store above 25°C. Protect from light. PACKAGING LDPE bags of 1kg, 5kg, 10kg, 25 kg and 50kg. Sealed 4 layer sachet (clay-coated paper/polyethylene/ aluminium foil/ionised) of 25g. Not all pack sizes may be marketed DISPOSAL Any unused product or waste material should be disposed of in accordance with national requirements. LEGAL CATEGORY POM PACKAGING 200 x 25 sachets VPA 10989/50/1

105


106


107


108


109


110


111


112


100 mg/ml solution for injection for cattle and pigs CATTLE Respiratory infections caused by Pasteurella spp. or Mycoplasma spp. Alimentary tract infections caused by E. coli. Treatment of local signs (inflammation, milk quality and yield) associated with peracute/acute mastitis in lactating dairy cattle caused by E. coli. PIGS Respiratory infections caused by of Pasteurella spp. or Mycoplasma spp. Alimentary tract infections caused by E. coli. Enrofloxacin should be used where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. PRESENTATION Solution for injection Clear slightly yellowish solution Each 1 ml of solution contains: 2.1 Active Constituents Enroloxacin 100.0 mg 2.2 Relevant Constituents of the Excipients Benzyl alcohol 7.8mg Disodium edetate 10.0mg LIST OF EXCIPIENTS Benzyl alcohol Disodium edetate Potassium hydroxide Glacial acetic acid Water for injections USES For the treatment of diseases in cattle and pigs involving organisms sensitive to Enrofloxacin, including Respiratory infections caused by Pasteurella spp. or Mycoplasma spp. Mastitic and Alimentary tract infections caused by E. coli. Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials. DOSAGE AND ADMINISTRATION To ensure correct dosage, body weight should be determined as accurately as possible to avoid underdosing. Cattle: For respiratory and alimentary infections in cattle and secondary bacterial infections: administer by subcutaneous injection. • 2.5 mg enrofloxacin per kg bodyweight daily by subcutaneous injection for 3 days (2.5 ml per 100 kg bodyweight). This rate may be doubled to 5 mg/kg bodyweight (5 ml per 100 kg) for 5 days for complicated respiratory disease. Not more than 10 ml should be administered at any one subcutaneous injection site. For E. coli mastitis: administer by slow intravenous injection. • 5.0 ml per 100 kg bodyweight (5 mg enrofloxacin per kg bodyweight) daily for 2 days Pigs:

For respiratory and alimentary infections in pigs and secondary bacterial infections: administer by intramuscular injection. 2.5 mg enrofloxacin per kg bodyweight daily by intramuscular injection for 3 days (2.5 ml per 100 kg bodyweight). This rate may be doubled to 5 mg/kg bodyweight (5 ml per 100 kg) for 5 days for complicated respiratory disease. Not more than 2.5 ml should be administered at any one intramuscular injection site. The stopper should not be punctured more than 20 times. CONTRAINDICATIONS AND WARNINGS i. Special precautions for use in animals The safety of the product has not been established in pigs or calves when administered by the intravenous route and use of this route of administration is not recommended in these animal groups. Do not exceed the recommended dose. Repeat injections should be administered at different sites. Enrofloxacin should be used with caution in epileptic animals or animals affected by renal dysfunction. Official and local antimicrobial policies should be taken into account when the product is used. Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials. Whenever possible, fluoroquinolones should only be used based on susceptibility testing. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other quinolones due to the potential for cross resistance. ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals The product is an alkaline solution. Wash any splashes from skin or eyes immediately with water. Do not eat, drink or smoke whilst using the product. Care should be taken to avoid accidental selfinjection. If accidental self injection occurs seek medical advice immediately. Direct contact with the skin should be avoided because of sensitisation, contact dermatitis and possible hypersensitivity reactions. Wear gloves. iii. Other precautions None known Adverse reactions (frequency and seriousness) Local tissue reactions may occasionally occur at the injection site. Normal sterile precautions should be taken. Rarely, anaphylactic reactions may occur following intravenous administration. In cattle, gastrointestinal disturbances may occasionally occur. Use during pregnancy, lactation or lay There is no restriction on the use of this product during pregnancy and lactation.

Interactions with other medicinal products and other form of interaction Antagonistic effects due to concurrent administration of macrolides, and tetracyclines may occur Enrofloxacin may interfere with the metabolism of theophylline, decreasing theophylline clearance resulting in increased plasma levels of theophylline. WITHDRAWAL PERIODS Cattle: Subcutaneous Use Meat and offal: 13 days Milk: 84 hours Cattle: Intravenous Use Meat and offal: 4 days Milk: 72 hours Pigs: Intramuscular Use Meat and offal: 10 days PHARMACEUTICAL PRECAUTIONS: In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products. SHELF LIFE: Shelf life of the veterinary medicinal product as packaged for sale: 2 years. Shelf life after first opening the immediate packaging: 28 days. SPECIAL PRECAUTIONS FOR STORAGE: Protect from light. Do not freeze SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED VETERINARY MEDICINAL PRODUCT OR WASTE DERIVED FROM THE USE OF SUCH PRODUCTS Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. LEGAL CATEGORY:

POM

PACKAGE QUANTITIES: Multi-dose glass vials MARKETING AUTHORISATION HOLDER: Bimeda Chemicals Ltd., Unit 2, Bryn Cefni Industrial Park, Llangefni, Anglesey, Wales, LL777XA MARKETING AUTHORISATION NUMBER: VPA 10516/001/001

113


114


115


116


117


118


119


Index A-M D

A ABINEX FORTE POUR-ON

12, 13

B BICOLOST B BILOSIN 200 INJECTION BIMADINE POWDER BIMASTAT BIMECTIN INJECTION BIMECTIN ORAL PASTE BIMECTIN PLUS BIMECTIN POUR-ON BIMOTRIM CO INJECTION BIMOXYL LA INJECTION BOVIFERM PLUS BOVIMAST DC BOVISAL PEARLS BOVISEAL NA

32, 33 14, 15 16, 17 22, 23 24, 25 26, 27 30, 31 28, 29 18, 19 20, 21 40, 41 38, 39 34, 35 36, 37

56, 57 58, 59

E ECTOFLITS ECTOFLY ECTOSPEC EFICUR 50 mg/ml EMBOTAPE ENDOSPEC 2.5% SC ENDOSPEC 10% ENDOFLUKE 10% EQUIBACTIN VET.

60, 61 62, 63 64, 65 66, 67 68, 69 70, 71 72, 73 74, 75 76, 77

F FLEE

78, 79

H

C CALCIUM BOVISAL CONVITAL EQUILYTES CONVITAL R CRONYXIN INJECTION CYCLOSOL LA CYCLO SPRAY CYPERGUARD

DIPEN D-MITE

42, 43 44, 45 46, 47 48, 49 52, 53 50, 51 54, 55

HELODIP HYSPAN

80, 81 82, 83

K KEFAMAST DC 84, 85 KEFAMAST LACTATING COW 86, 87

M MULTIMAST DRY COW

120

88, 89


Index O-Z N NEFOTEK

U 90, 91

O OSMODEX OXYCOMPLEX NS OXYTOCIN Pro Injection

92, 93 94, 95 96, 97

UNISOL

112, 113

V VETRUSIL INJECTION VITAMIN B1 INJECTION VITAMIN K1 INJECTION

114, 115 116, 117 118, 119

R RAPIDEXON

98, 99

S SEDAXYLAN SELECTAN SODIUM POWDER

100, 101 102, 103 104, 105

T TETROXY LA TONAVET TYLOVET 20%

106, 107 108, 109 110, 111

121


Your Local Representative from Bimeda Andrew Glynn, Sales Manager for Ireland (Veterinary and Co Operatives) aglynn@bimeda.com 087 2525110

Shane Kinsella, Co Operative Sales Representative (Munster & Leinster) skinsella@bimeda.com 086 0493960

Denis Carney, Veterinary sales Representative (South East Ireland), dcarney@bimeda.com 087 2576925

Morgan Lane, Co Operative Sales Representative (West of Ireland & Midlands) mlane@bimeda.com 087 2568346

John Reynolds, Veterinary Sales Representative (Dublin, Midlands and West of Ireland) jreynolds@bimeda.com 087 8097059

Paudie Hyland Bimeda Commercial Vet phyland@bimeda.com 086 0433388

John Sheerin Veterinary Sales Representative (Munster) jsheerin@bimeda.com 087 2576926

122


www.bimeda.ie


Product_Compendium_Ire_Collated_29-03-2012-reduced